-
Loading metrics
Open Access
Peer-reviewed
Research Article
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer
-
Tatsuaki Takeda,
Affiliation Department of Clinical Pharmacy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Hiromasa Yamamoto,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Hirotaka Kanzaki,
Affiliation Department of Clinical Pharmacy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Ken Suzawa,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Takahiro Yoshioka,
Affiliation Department of Clinical Genomic Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Shuta Tomida,
Affiliation Department of Biobank, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Xiaojiang Cui,
Affiliation Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Ramachandran Murali,
Affiliation Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
⨯ -
Kei Namba,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Hiroki Sato,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Hidejiro Torigoe,
Affiliations Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan, Department of Clinical Genomic Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Mototsugu Watanabe,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Kazuhiko Shien,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Junichi Soh,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Hiroaki Asano,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Kazunori Tsukuda,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Yoshihisa Kitamura,
Affiliation Department of Clinical Pharmacy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Shinichiro Miyoshi,
Affiliation Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ -
Toshiaki Sendo,
Affiliation Department of Clinical Pharmacy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ - [ ... ],
-
Shinichi Toyooka
* E-mail: toyooka@md.okayama-u.ac.jp
Affiliations Department of Thoracic, Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan, Department of Clinical Genomic Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan
⨯ - [ view all ]
- [ view less ]
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer
- Tatsuaki Takeda,
- Hiromasa Yamamoto,
- Hirotaka Kanzaki,
- Ken Suzawa,
- Takahiro Yoshioka,
- Shuta Tomida,
- Xiaojiang Cui,
- Ramachandran Murali,
- Kei Namba,
- Hiroki Sato
- Published: February 3, 2017
- https://doi.org/10.1371/journal.pone.0171356